One top biotech analyst says Moderna is going even higher here

About This Source - CNBC Television

CNBC is an American pay television business news channel, which primarily carries business day coverage of U.S. and international financial markets. Following the end of the business day and on non-trading days, CNBC primarily carries financial and business-themed documentaries and reality shows.

As of February 2015, CNBC is available to approximately 93,623,000 pay television households (80.4% of households with television) in the United States.

Recent from CNBC Television:

  • Cerence CEO: How semiconductor shortage impacts business
  • One dead after man accidentally drives truck into group at pride parade in Florida
  • Small Business Association program leaves venues shuttered
  • CNBC Television published this video item, entitled “One top biotech analyst says Moderna is going even higher here” – below is their description.

    Hartaj Singh, Oppenheimer sr. biotech analyst, on Moderna and Johnson & Johnson following the decision to pause using the JNJ vaccine. With CNBC’s Melissa Lee and the Fast Money traders, Guy Adami, Tim Seymour, Jeff Mills and Steve Grasso.

    CNBC Television YouTube Channel

    Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

    In This Story: Moderna

    Moderna is an American biotechnology company based in Cambridge, Massachusetts that focuses on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA.

    CEO: Stéphane Bancel (2011–)

    Stock ticker: (NASDAQ:MRNA)

    5 Recent Items: Moderna

  • What do the new loosened travel restrictions mean for fully-vaccinated Canadians and residents?
  • Mixing COVID-19 mRNA vaccines is safe and effective, experts stress
  • Global National: June 21, 2021 | Canada loosens travel restrictions for fully vaccinated residents
  • Fully vaccinated Canadians can enter country without quarantine starting July 5 | FULL
  • COVID vaccines increasingly tested on children
  • Leave a Comment